HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

5th Edition of Cardiology World Conference

September 5-7, 2024 | Madrid, Spain

September 05 -07, 2024 | Madrid, Spain

Cardio 2023

Yochai Birnbaum, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Yochai Birnbaum, Baylor College of Medicine, United States

For years aspirin was considered an essential part of the treatment of patients with or at risk of coronary artery disease. However, more recent studies have shown that aspirin, even at low dose, does not improve outcomes when administered for primary prevention and is associated [....] » Read More

Timothy F Christian, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Timothy F Christian, Albert Einstein College of Medicine, United States

The use of multiple noninvasive tests in a patient for a specific question in cardiology is becoming more common. While it is expected that each new piece of test information will align, the reality is that each test carries strengths and weaknesses that generate a profile of acc [....] » Read More

Corina Rosales, Speaker at Cardiology Conference
Oral Presentation (In-Person)
Corina Rosales, Houston Methodist Research Institute, United States

Although plasma HDL-C levels negatively correlate with atherosclerotic cardiovascular disease (ACVD), attempts to reduce ACVD risk by raising plasma HDL have disappointed. Thus, hypotheses about salutary HDL effects have shifted from higher-is-better to function-is-more-important [....] » Read More

Syeda Anum Zahra, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Syeda Anum Zahra, Imperial College NHS Trust, United Kingdom

Introduction: Although majority of patients have essential hypertension, secondary hypertension can also cause significant cardiovascular events. Secondary hypertension is defined as hypertension due to an identifiable cause and has a prevalence of 5-10%. European Society of Card [....] » Read More

Marianne Reimers Wessberg, Speaker at Heart Conferences
Oral Presentation (In-Person)
Marianne Reimers Wessberg, Karolinska Institute, Sweden

Background: Heart failure (HF) is globally the most common cause for admission to hospital for patients 65 years and older in high income countries. Research on HF has however often focused on younger patients. The aim of these studies was to analyze extent of investigation and t [....] » Read More

Nindorera Felix, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Nindorera Felix, UCLouvain, Belgium

Background: Post-stroke mobility deficits and physical inactivity are highly prevalent. Although physical activity has been shown to be effective for poststroke people, access to exercise training protocols is limited in community especially low-income settings. In addition, the [....] » Read More

Sasa Kacar, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Sasa Kacar, University Clinical Center of Serbia, Serbia

Post-infarction ventricular septal defect rupture (PIVSR) is rare but highly lethal complication of acute myocardial infarction. Even with well-established surgical treatment (David’s or Daggett’s technique), 30-days mortality is still high, more than 40%. The mo [....] » Read More

Wilson Saputra Wijaya, Speaker at Heart Conferences
Oral Presentation (In-Person)
Wilson Saputra Wijaya, Trisakti University, Indonesia

Group A Streptococcus (GAS) is a global burden, including in Indonesia, with long-term morbidity and mortality complications. The different response to nephrogenic and rheumatogenic strain makes concurrent post-streptococcal glomerulonephritis with acute rheumatic fever a rarity. [....] » Read More

Dhulipalla Dharma Teja, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Dhulipalla Dharma Teja, NRI Medical College, India

Introduction: Cancer therapy-related cardiac dysfunction (CTRCD) is one of the side effects experienced by nearly one-tenth of cancer survivors. LVEF and GLS have been proposed as a marker to predict CTRCD. Recent studies also suggest assessment of cardiac biomarkers including tr [....] » Read More

Anuja Waidande, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Anuja Waidande, Bharti Vidyapeeth Medical College and Hospital, India

We present a case of a 43-year-old man, a known case of hypertension, who was diagnosed with acute myocardial infarction for which he was given streptokinase (Fibrinolytic drug).He presented to the hospital with exertional dyspnoea and chest pain. Angiogram showed triple-vessel d [....] » Read More

Shivling Sanjay Swami, Speaker at Heart Conferences
Oral Presentation (In-Person)
Shivling Sanjay Swami, Bharti Vidyapeeth Medical College and Hospital, India

Introduction: It is an alarming observation that one third of all women in their fourth decade will develop coronary artery disease(1). Moreover, young women who develop coronary artery disease have a higher morbidity and mortality as compared to men of same age. (1,2) Traditiona [....] » Read More

Linda Shirindi, Speaker at Heart Conferences
Oral Presentation (In-Person)
Linda Shirindi, University of South Africa, South Africa

Stakeholder collaboration is significant to the contribution and improvement of psycho-social functioning and resilience of women living with hypertension. The purpose of the study was to explore and describe perceptions of stakeholders in addressing psycho-social needs of women [....] » Read More

Volodymyr Popov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Volodymyr Popov, Amosov National Institute of Cardiovascular Surgery, Ukraine

Purpose: To determine the possibilities of surgical treatment of  myxomas  of the heart (MH). Material and methods: In  Institute for period from 1.01.1969 to 1.01.2020  957 patients (pts) with the verified primary tumors of heart were operated . The MH [....] » Read More

 Valery Boukarim, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Valery Boukarim, Amosov National Institute of Cardiovascular Surgery, Ukraine

Objective: To determined  possibillities of left atrium (LA)`s reduction by original method of arch plasty of LA (APLA) during mitral valve replacement (MVR) for isolated mitral valve disease (MVD). Methods: During 2005 – 2021 yy. 454  adult patients [....] » Read More

Evgen Novikov, Speaker at Heart Conferences
Oral Presentation (In-Person)
Evgen Novikov, Amosov National Institute of Cardiovascular Surgery, Ukraine

Objective: To analyzed main problems  in surgery of  mitral valve diseases (MVD) complicated by left atrium`s massive thromboses (LAMT) (thromboses more than 1/3 of left atrium`s volume). Materials and Methods: 336 adult patients (pts) with MVD complicated LA [....] » Read More

Volodymyr Popov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Volodymyr Popov, Amosov National Institute of Cardiovascular Surgery, Ukraine

Objective: To determined  possibillities of left atrium (LA)`s reduction by original method of triangular plasty of LA (TPLA) during  valve`correction replacement. Methods: During 2005 – 2021 yy. 725  adult patients (pts) with  MVD and LA`s at [....] » Read More

Gurtovenko Alexey, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Gurtovenko Alexey, Amosov National Institute of Cardiovascular Surgery, Ukraine

Objective: -To present analysis of retrograde crystalloid cardioplegia during isolated mitral valve  replacement (MVR) . Materials and Methods: -During 2009-2020 y 529 patients (pts)  with isolated pathology of mitral valve disease (MVD) were operated by MVR in departm [....] » Read More

Chan Young Na, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Chan Young Na, Dontan Hospital, Korea, Republic of

Background and objectives: Left ventricular free rupture is rare and one of the fatal complications after acute myocardial infarction. Early recognition and aggressive treatment is recommended. Methods: Between August 1999 and February 2023, eleven patients with ages [....] » Read More

Qazi Naeem Ur Rehman, Speaker at Heart Conferences
Poster Presentation (In-Person)
Qazi Naeem Ur Rehman, Wirral University Hospital, United Kingdom

Rheumatic fever is the most common cause of mitral stenosis and carries a high degree of morbidity in pregnant females adverse foetal outcomes are associated with mitral stenosis in pregnancy. Pathophysiology, symptoms and diagnosis of rheumatic valve stenosis during pregnan [....] » Read More

Javier Lozano, Speaker at Heart Conferences
Poster Presentation (In-Person)
Javier Lozano, University of the Philippines, Philippines

When a myocardial infarction (MI) takes place, a process of cardiac remodelling follows. This is necessary to resolve the reduced or blocked flow of blood into the stressed or dying cardiac tissue. This includes the formation of scar tissue and deposition of extracellular matrix [....] » Read More

Al James A Manua, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Al James A Manua, University of the Philippines, Philippines

In this study, we investigated the shared key genes, pathway networks, and transcription factors (TFs) associated with Cardiac Fibrosis following Acute Myocardial Infarction (AMI) in mouse models. Gene expression profiles of AMI and the sham-control group were obtained from the [....] » Read More

Mariel Lizbeth Joy Agsaoay, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Mariel Lizbeth Joy Agsaoay, University of the Philippines, Philippines

Cardiovascular diseases (CVDs) have remained the leading cause of global mortality. Of these, one of the main events leading to death is myocardial infarction (MI), followed by cardiac fibrosis. To better understand the disease and its development, various techniques [....] » Read More

Mekhman N Mamedov, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation

In the first decades of the 21st century, chronic noncommunicable diseases (CNCDs) remain the leading cause of disability and death among adults in the developed world. Their total share in mortality is about 77%. Malignant oncological diseases, along with cardiovascular diseases [....] » Read More

Kate Tauber, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Kate Tauber, Albany Medical Center, United States

Congenital heart disease is one of the more common congenital anomalies with an incidence of approximately 4 per 1000 live births.  Although many of these infants are born at term with birthweights well within the normal range, they often can develop growth failure due to in [....] » Read More

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Syed Raza, Awali Hospital, Bahrain

Dyslipidaemia comprises of abnormal lipid components and refers mainly to increased levels of LDL, non HDL particles and triglycerides while decreased levels of HDL Dyslipidaemia is a common and independent modifiable risk factor for cardiovascular disease. Be [....] » Read More

Barbara, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Barbara, Sapienza University of Rome, Italy

Cardiovascular disease is the leading cause of mortality for women and is responsible for 35% of total deaths in women, since there is a growing interest (as the Lancet Commission alert) on reducing the global burden of cardiovascular disease. It is estimated that obesity contrib [....] » Read More

Yanqin Cui, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Yanqin Cui, Guangzhou Women and Children's Medical Center, China

Background: Congenital heart disease (CHD) remains one of the leading causes of infant and postneonatal mortality. Early recognition and successful management of critically ill CHD patients is a difficult challenge considering the complexity of the anatomy and physiopathology of [....] » Read More

Xue Wang, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Xue Wang, Beijing University of Chinese Medicine, China

Objective: With the help of CiteSpace software platform, a visual analysis was carried out around the literature on the relationship between "hyperuricemia" and "insulin resistance", to explore the relationship between the two, and to summarize and predict the [....] » Read More

Sheefah Dhuny, Speaker at Heart Conferences
Oral Presentation (Virtual)
Sheefah Dhuny, Salford Royal Hospital, United Kingdom

Background: Following an acute coronary syndrome (ACS), a patient’s ability to drive might be impaired and the Driver and Vehicle Licensing Agency (DVLA) provides guidance on driving restrictions post-ACS. The medical team is responsible for informing patients of drivi [....] » Read More

Neelesh Kumar S Shah, Speaker at Heart Conferences
Oral Presentation (Virtual)
Neelesh Kumar S Shah, Tumkur Cardiac Care, India

Objective: To compare the levels of microRNA (miRNA) 24 levels in diabetic patients with acute coronary syndrome (ACS) with non-diabetics suffering from ACS. Methodology: A prospective case-control study was carried out among 40 patients with ACS residing in Belagavi, Karnatak [....] » Read More

Swetha Kannan, Speaker at Heart Conferences
Oral Presentation (Virtual)
Swetha Kannan, Gulf Medical University, United Arab Emirates

The risk of cardiovascular disease increases at an alarming rate with the increase in an individual’s blood pressure. Rise in systemic arterial blood pressure can be caused by factors such as unhealthy diet (excessive intake of salts, trans-fats and saturated fats), alcohol [....] » Read More

Aditi Parulkar, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Aditi Parulkar, Parulkar Hospitals, India

Epicardial adipose tissue is an area of multidisciplinary interest and tremendous potential for upcoming research. It is composed of adipocytes as well as inflammatory cells, nervous cells, vascular cells and immune cells. It has multiple protective functions and has fu [....] » Read More

Shreenithi J, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Shreenithi J, Stanley Medical College, India

HIV infection is associated with high rates of Cardiovascular disease complications, including acute myocardial infarction, sudden cardiac death, and heart failure. It has been found that patients with HIV have a 2-fold risk of Cardiovascular disease and 50 percent increased [....] » Read More

Azamat Baymukanov, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Azamat Baymukanov, Moscow City Clinical Hospital After V.M. Buyanov, Russian Federation

Objectives: To investigate the prevalence of obstructive sleep apnea (OSA), anthropometric and clinical characteristics of patients with atrial fibrillation (AF), and assess the possibilities of screening diagnosis for OSA. Materials and Methods: The study involved AF patients ( [....] » Read More

Mohamed waheeb, Speaker at Heart Conferences
Oral Presentation (Virtual)
Mohamed waheeb, Curative organization, Egypt

Introduction: Rib fractures are a frequently identified injury in the trauma population. Nonoperative treatment is based on pain control and aggressive supportive pulmonary care primarily aimed at avoiding the need for intubation, which is associated with increased rates of pneum [....] » Read More

 Jelena Petrovic, Speaker at Heart Conferences
Oral Presentation (Virtual)
Jelena Petrovic, University Clinical Center of Serbia, Serbia

Widespread knowledge and awareness of Modifiable Cardiovascular Risk Factors (MCRF) may be essential to reduce the burden of Cardiovascular Diseases (CVD). However, the lack of Doctor-Patient Communication (DPC) about personal Cardiovascular Risk (pCVR) could have negative i [....] » Read More

Saad Bin Zafar Mahmood, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Saad Bin Zafar Mahmood, Aga Khan University, Pakistan

Premature Atherosclerotic cardiovascular disease (ASCVD) represents a growing challenge that needs more attention to be addressed in early adulthood. It correlates highly with dyslipidaemia, male sex, smoking, inflammatory disease, hypertension, and family history of premature AS [....] » Read More

Yeganeh Mobasser, Speaker at Heart Conferences
Oral Presentation (Virtual)
Yeganeh Mobasser, MUMS, Iran (Islamic Republic of)

Despite evidence showing the effect of vasoactive hormones including aldosterone in pulmonary arterial hypertension (PAH) pathophysiology, few clinical reports are available concerning the effect of PAH treatment with aldosterone antagonists. Therefore, in this study, we evaluate [....] » Read More

Nahid Mobasser, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Nahid Mobasser, ZUMS, Iran (Islamic Republic of)

Purpose: The purpose of this study was to investigate the effect of exercise training on exercise tolerance and left ventricular diastolic function and structure in patients with chronic cardiac ischemia. Methods: Eighty-eight patients with cardiac ischemia and diastolic disfu [....] » Read More

Jake Kieserman, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Jake Kieserman, Hospital of the University of Pennsylvania, United States

Background:Myopericarditis is a rare complication of the mRNA Covid-19 vaccines, and often affects young males. We present a case of myopericarditis in a 68-year-old male with AML after receiving the 2nd booster (4th dose) of mRNA-1273 (Moderna booster). Case:A 68-year-old mal [....] » Read More

Ayan Ali, Speaker at Heart Conferences
Oral Presentation (Virtual)
Ayan Ali, Hospital of The University of Pennsylvania, United States

Background: The clinical presentation of viral myocarditis is variable and is an important cause of cardiomyopathy worldwide. In some cases, symptoms are minimal consisting of mild fatigue and chest discomfort, where other cases result in fulminant heart failure, arrythmia and su [....] » Read More

Asma Syed, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Asma Syed, Brookdale Hospital Medical Center, United States

Sudden Cardiac Death (SCD) is one of the leading causes of death world wide. It is caused by ventricular arrhythmias and usually occurs suddenly without much notice. SCD can occur in patients with structural abnormal hearts specifically the patient with left sided systo [....] » Read More

Faris Halaseh, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Faris Halaseh, Irvine School of Medicine, United States

Background: There are a multitude of barriers that can lead to poor cardiac outcomes in the United States, especially those faced by underrepresented and minority populations. The development of new advancements in the field of Artificial Intelligence has become a primary to [....] » Read More

Joao Rafael Rocha da Silva, Speaker at Heart Conferences
Oral Presentation (Virtual)
Joao Rafael Rocha da Silva, Connect Life Rehabilation And Performance, Brazil

Introduction: Cardiovascular Diseases are responsible for substantial damage to the health system, being the main cause of mortality in the world, just as Pain is the main cause of disability in the world. It is common for individuals diagnosed with both pathologies as well as ot [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Heart Conferences
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Rationale: A novel COVID-19 with a severe acute respiratory syndrome or pneumonia had arisen in Wuhan, China in December 2019. Emerging atrial fibrillation in COVID-19 patients is highly significant in cardiovascular medicine. A newly coronary artery spasm in the presentation of [....] » Read More

Jessica Edith Rodriguez Rodriguez, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Jessica Edith Rodriguez Rodriguez, National Autonomous University of Mexico, Mexico

a1D-adrenoceptor (a1D-AR) is a G-coupled receptor involved in blood pressure regulation, so far, its activity has been determined using BMY 7378, a drug with high affinity for them; but, with some other therapeutic blanks, as 5HT1 receptors, which could contribute indirectly with [....] » Read More

 Hamza Abushuqeir, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Hamza Abushuqeir, Yarmouk University, Jordan

Atrial fibrillation (AF) is a common arrhythmia characterized by rapid, irregular electrical activity in the atria of the heart. It is associated with significant morbidity and mortality, and its prevalence is increasing worldwide. The major cardiac causes of AF include hypertens [....] » Read More

Wen Jie Chin, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Wen Jie Chin, New Cross Hospital, United Kingdom

Introduction Antiphospholipid syndrome (APS) is a disorder of autoimmune system presented clinically by arterial or venous thrombosis. One of the rare and severe forms of APS is known as catastrophic APS (CAPS). The incidence of CAPS has been reported in 0.8% of patients with AP [....] » Read More

Yasir Bakhit, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Yasir Bakhit, Oxford University Hospitals NHS Trust, United Kingdom

Background: Brugada syndrome is a rare diagnosis with a prevalence of 3 to 5 per 10,000, accounting for 4% of all sudden cardiac deaths. It can present with ventricular tachyarrhythmia and sudden cardiac deaths in structurally normal hearts, with an autosomal dominant patter [....] » Read More

Mayur Mayabhate, Speaker at Cardiology Conferences
Poster Presentation (In-Person)
Mayur Mayabhate, Alkem Laboratories Ltd, India

Introduction: Sacubitril/valsartan in one of the pillars of fantastic four and has been established as an effective treatment for heart failure (HF) with reduced ejection fraction based on clinical trial data; however, little is known about its use or impact in real-world practic [....] » Read More

Alexander Suchodolski, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Alexander Suchodolski, Silesian Center of Heart Disease in Zabrze, Poland

This presentation summarizes the clinical and radiological characteristics of patients with an anomalous origin of the left circumflex artery from the right sinus of Valsalva (RCx), diagnosed by cardiac computed tomography (CT). This anomaly is a rare type of anomalous aortic ori [....] » Read More

Sanya Ahmed, Speaker at Heart Conferences
Poster Presentation (Virtual)
Sanya Ahmed, SUNY Downstate College of Medicine, United States

Purpose:High levels of coronary artery stenosis (>50%) increases the risk for ischemic heart disease, the leading cause of death worldwide. A novel procedure called intravascular lithotripsy (IVL) can reduce the levels of coronary artery stenosis by disrupting calcified plaque [....] » Read More

Jenakan Dev, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Jenakan Dev, Cape Canaveral Hospital, United States

A 75-year-old male with hypertension and GERD, who was a lifelong non-smoker, and consumes very little alcohol presented to our service with acute epigastric pain. He complained of intermittent mild nausea for the past 6 months. CT scan of the abdomen & pelvis showed acute pa [....] » Read More

Nacole Riccaboni, Speaker at Heart Conferences
Poster Presentation (Virtual)
Nacole Riccaboni, Orlando Health Heart & Vascular Institute, United States

One million hospital admissions annually in the United States (US) are due to heart failure, with heart failure being the principal cause of 30-day readmissions. The major health problem with individuals diagnosed with heart failure is its high incidents of hospitalizations and r [....] » Read More

Jenakan Dev, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Jenakan Dev, Cape Canaveral Hospital, United States

A 27year old female with a history of Roux-en-Y gastric bypass, complicated by gastrojejunal anastomotic stricture resulting in Wernicke’s encephalopathy due to thiamine deficiency was admitted to our service for persistent tachycardia, palpitations, symptomatic orthostatic [....] » Read More

Sumit Khurana, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Sumit Khurana, MedStar Health, United States

Pulmonary arteriovenous malformations (PAVM’s) are structurally abnormal vascular communications between pulmonary arteries and veins that range in size and complexity and contribute to an anatomic right-to-left shunt. They can present with varied symptoms including dyspnea [....] » Read More

Ronald Sperry, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Ronald Sperry, Texas A&M School of Engineering Medicine, United States

Introduction/Background: Digital stethoscopes enhance the diagnostic power of auscultation through noise cancellation, waveform analysis, telehealth integration, and collaborative potential. Unfortunately, current products lack a cost-effective solution for synchronized listening [....] » Read More

Will be updated soon......
Watsapp